377
Views
5
CrossRef citations to date
0
Altmetric
Original Article

The role of fetal growth restriction in the association between Down syndrome and perinatal mortality

, , , , , & show all
Pages 952-960 | Received 12 Apr 2018, Accepted 10 Aug 2018, Published online: 10 Sep 2018

References

  • Parker SE, Mai CT, Canfield MA, et al. Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008–1016.
  • Ferreira JCP, Grati FR, Bajaj K, et al. Frequency of fetal karyotype abnormalities in women undergoing invasive testing in the absence of ultrasound and other high-risk indications. Prenat Diagn. 2016;36(12):1146–1155.
  • Hook EB, Cross PK, Schreinemachers DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA. 1983;249(15):2034–2038.
  • Snijders RJ, Sundberg K, Holzgreve W, et al. Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol. 1999;13(3):167–170.
  • Mathews TJ, Hamilton BE. Mean age of mothers is on the rise: United States, 2000-2014. NCHS Data Brief. 2016;232(232):1–8.
  • Weijerman ME, van Furth AM, Vonk Noordegraaf A, et al. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. J Pediatr. 2008;152(1):15–19.
  • Egan JFX, Smith K, Timms D, et al. Demographic differences in Down syndrome livebirths in the US from 1989 to 2006. Prenat Diagn. 2011;31(4):389–394.
  • Norton ME, Brar H, Weiss J, et al. Non-Invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012;207(2):137.e1–137.e8.
  • Fairbrother G, Burigo J, Sharon T, et al. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis. J Matern Fetal Neonatal Med. 2016;29(7):1160–1164.
  • Iwarsson E, Jacobsson B, Dagerhamn J, et al. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population – a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2017;96(1):7–18.
  • Ni She R, Filan PM. Trisomy 21 – incidence and outcomes in the first year, in Ireland today. Ir Med J. 2014;107(8):248–249.
  • Sparks TN, Griffin E, Page J, et al. Down syndrome: perinatal mortality risks with each additional week of expectant management. Prenat Diagn. 2016;36(4):368–374.
  • Alldred SK, Takwoingi Y, Guo B, et al. First trimester serum tests for Down’s syndrome screening. Cochrane Database Syst Rev. 2015;11(11):CD011975–CD011975.
  • Trudell AS, Cahill AG, Tuuli MG, et al. Stillbirth and the small fetus: use of a sex-specific versus a non-sex-specific growth standard. J Perinatol. 2015;35(8):566–569.
  • Norris T, Johnson W, Farrar D, et al. Small-for-gestational age and large-for-gestational age thresholds to predict infants at risk of adverse delivery and neonatal outcomes: are current charts adequate? An observational study from the born in bradford cohort. BMJ Open. 2015;5(3):e006743.
  • Bukowski R, Hansen NI, Willinger M, et al. Fetal growth and risk of stillbirth: a population-based case-control study. PLOS Med. 2014;11(4):e1001633.
  • Pilliod RA, Cheng YW, Snowden JM, et al. The risk of intrauterine fetal death in the small-for-gestational-age fetus. Am J Obstet Gynecol. 2012;207(4):318.e1–318.e6.
  • Pierce BT, Martin LS, Hume RF, et al. Relationship between the extent of histologic villous mineralization and stillbirth in aneuploid and euploid fetuses. J Soc Gynecol Investig. 2002;9(5):290–293.
  • Joseph KS, Huang L, Liu S, et al. Reconciling the high rates of preterm and postterm birth in the United States. Obstet Gynecol. 2007;109(4):813–822.
  • Ananth CV. Menstrual versus clinical estimate of gestational age dating in the United States: temporal trends and variability in indices of perinatal outcomes. Paediatr Perinat Epidemiol. 2007;21(Suppl 2):22–30.
  • Zhang J, Merialdi M, Platt LD, et al. Defining normal and abnormal fetal growth: promises and challenges. Am J Obstet Gynecol. 2010;202(6):522–528.
  • Smith GC. Life-table analysis of the risk of perinatal death at term and post term in singleton pregnancies. Am J Obstet Gynecol. 2001;184(3):489–496.
  • Gelfand LA, MacKinnon DP, DeRubeis RJ, et al. Mediation analysis with survival outcomes: accelerated failure time vs. proportional hazards models. Front Psychol. 2016;7:423.
  • VanderWeele TJ. Causal mediation analysis with survival data. Epidemiology. 2011;22(4):582–585.
  • Ananth CV, VanderWeele TJ. Placental abruption and perinatal mortality with preterm delivery as a mediator: disentangling direct and indirect effects. Am J Epidemiol. 20111;174(1):99–108.
  • Buis ML. Direct and indirect effects in a logit model. STATA J. 2010;10(1):11–29.
  • Oxvig C. The role of PAPP-A in the IGF system: location, location, location. J Cell Commun Signal. 2015;9(2):177–187.
  • Gupta MB. The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction. J Cell Commun Signal. 2015;9(2):111–123.
  • Corry E, Mone F, Segurado R, et al. Placental disease and abnormal umbilical artery Doppler waveforms in trisomy 21 pregnancy: a case-control study. Placenta. 2016;47:24–28.
  • Figueras F, Gratacos E. Stage-based approach to the management of fetal growth restriction. Prenat Diagn. 2014;34(7):655–659.
  • Morris JK, Cole TJ, Springett AL, et al. Down syndrome birth weight in England and Wales: implications for clinical practice. Am J Med Genet A. 2015;167A(12):3070–3075.
  • Salemi JL, Tanner JP, Sampat DP, et al. Evaluation of the sensitivity and accuracy of birth defects indicators on the 2003 revision of the U.S. Birth certificate: has data quality improved? Paediatr Perinat Epidemiol. 2017;31(1):67–75.
  • Morris JK, Alberman E. Trends in Down’s syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down syndrome Cytogenetic Register. BMJ. 2009 26;339:b3794.
  • Yudkin PL, Wood L, Redman CW. Risk of unexplained stillbirth at different gestational ages. Lancet. 1987;1(8543):1192–1194.
  • Ferguson R, Myers SA. Population study of the risk of fetal death and its relationship to birthweight, gestational age, and race. Am J Perinatol. 1994;11(4):267–272.
  • Chard T. Does the fetus lose weight in utero following fetal death: a study in preterm infants. BJOG. 2001;108(11):1113–1115.
  • Morris JK, Wald NJ, Watt HC. Fetal loss in Down syndrome pregnancies. Prenat Diagn. 1999;19(2):142–145.
  • Turan OM, Turan S, Gungor S, et al. Progression of Doppler abnormalities in intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008;32(2):160–167.
  • Odibo AO, Goetzinger KR, Cahill AG, et al. Combined sonographic testing index and prediction of adverse outcome in preterm fetal growth restriction. Am J Perinatol. 2014;31(2):139–144.
  • Crimmins S, Desai A, Block-Abraham D, et al. A comparison of Doppler and biophysical findings between liveborn and stillborn growth-restricted fetuses. Am J Obstet Gynecol. 2014;211(6):669.e1–669.10.
  • Hershkovitz R, Kingdom JC, Geary M, et al. Fetal cerebral blood flow redistribution in late gestation: identification of compromise in small fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol. 2000;15(3):209–212.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.